Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 13,009 | 10,409 | 6,951 | 2,871 | 1,890 |
| Operating Income | -13,009 | -10,409 | -6,951 | -2,871 | -1,890 |
| Other Income | 234 | 521 | -95 | 82 | 1,231 |
| Pre-tax Income | -12,775 | -9,888 | -7,046 | -2,789 | -659 |
| Net Income Continuous | -12,775 | -9,888 | -7,046 | -2,789 | -659 |
| Net Income | $-12,775 | $-9,888 | $-7,046 | $-2,789 | $-659 |
| EPS Basic Total Ops | -0.64 | -0.52 | -0.47 | -0.22 | -0.06 |
| EPS Basic Continuous Ops | -0.64 | -0.52 | -0.47 | -0.22 | -0.06 |
| EPS Diluted Total Ops | -0.64 | -0.52 | -0.47 | -0.22 | -0.06 |
| EPS Diluted Continuous Ops | -0.64 | -0.52 | -0.47 | -0.22 | -0.06 |
| EBITDA(a) | $-13,009 | $-10,409 | $-6,951 | $-2,871 | $-1,890 |